| Anna Ryan, | |
|
3280 Dauphin St Ste A103, Mobile, AL 36606-4048 | |
| (251) 459-8402 | |
| Not Available |
| Full Name | Anna Ryan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3280 Dauphin St Ste A103, Mobile, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083243240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP4681 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anna Ryan, 251 Johnston St Se Ste 200, Decatur, AL 35601-2515 Ph: (256) 350-1764 | Anna Ryan, 3280 Dauphin St Ste A103, Mobile, AL 36606-4048 Ph: (251) 459-8402 |
News Archive
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals (Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to develop and commercialize Santhera's JP-1730/fipamezole for the treatment of Dyskinesia in Parkinson's Disease (DPD). JP-1730/ fipamezole is a first-in-class compound that, in a recent Phase IIb study, displayed the potential to reduce levodopa-induced dyskinesia.
Pfizer Inc. and Excaliard Pharmaceuticals, Inc. announced today that they have entered into a definitive agreement under which Pfizer will acquire Excaliard, a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring. The acquisition is expected to close before the end of the year.
MDS Nordion, a leading provider of products and services to the global health science market, today announced it has signed a new contract with its primary customer, Lantheus Medical Imaging, Inc. for the supply of Molybdenum-99.
Research at Oregon State University has found that one particular omega-3 fatty acid has a powerful effect in preventing liver inflammation and fibrosis - common problems that are steadily rising along with the number of Americans who are overweight.
Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism.
› Verified 7 days ago
Kelli Jo Evans, PHD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5721 Usa North Dr, Hahn 1119, Mobile, AL 36688 Phone: 251-445-9378 Fax: 251-445-9377 | |
Reach Pediatric Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12485 Jeff Hamilton Rd, Mobile, AL 36695 Phone: 251-259-2430 | |
Rebecca Black, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Somerby Dr, Mobile, AL 36695 Phone: 251-633-4447 Fax: 251-633-4141 | |
Kimberley Meyer Warner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7158 Wynnridge Dr, Mobile, AL 36695 Phone: 251-634-4974 | |
Cheryl Pugh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4720 Morrison Dr, Mobile, AL 36609 Phone: 877-787-3422 | |
Rebecca Clara Eskridge, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 C East Portier Ct., Mobile, AL 36607 Phone: 251-605-1334 | |
Victoria Rhea Childs, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1504 Spring Hill Ave, Mobile, AL 36604 Phone: 251-219-3923 Fax: 251-219-3750 |